Spinout Active LTD

Company profile

Protondx Ltd

Home | ProtonDX

Because your organisation needs certainty when testing for Covid-19

CRN
12534364
Founded
2020
Age
6

Overview

Browse spinouts
Legal name
PROTONDX LTD
Region
Unknown
Registered address
I-HUB
84 WOOD LANE
LONDON
ENGLAND
W12 0BZ
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
-£3,139,785
Employees
17

Company events

Reference milestones and recent Companies House filing stream events.

8 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

06 Feb
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

24 Feb
2025

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQ1NjE0NDM2MGFkaXF6a2N4

Published 24 Feb 2025 12:18

24 Feb
2025

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQ1NjEzOTk5N2FkaXF6a2N4

Published 24 Feb 2025 11:45

23 Jan
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

14 Oct
2024

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzQzODcyNzExMGFkaXF6a2N4 | Paper/PDF filed

Published 16 Oct 2024 06:55

25 Mar
2020

Incorporated

Inception

Company registered at Companies House

Spinout profile

2 entries

Company description

ProtonDx develops a diagnostic device for COVID-19

Project impact

Earlier this year, we launched the Dragonfly Diagnostic Platform, a rapid, portable, and accurate diagnostic product. ? Dragonfly combines portability, speed, high sensitivity, high specificity, and convenience to differentiate and detect multiple pathogens from a single sample in less than 30 minutes. ? High quality DNA and RNA samples are extracted from nasopharyngeal swabs and prepared for testing with minimal handling, providing results equivalent to the 'gold standard' polymerase chain reaction test (PCR) at point of need. In addition, the Dragonfly platform provides confidence that the patient sample has been taken and tested correctly. ? Dragonfly test panels are available to detect a variety of pathogens. ? The Dragonfly system is a CE marked in vitro diagnostic medical device and complies with the current European In vitro Diagnostic Devices Directive (IVDD 98/79/EC). ? The latest news of Dragonfly being used at the Commonwealth Games 2022 can be found here

ProtonDx
2020
ProtonDx
2020

Public funding

2 awards
First funded
2022
Funded years
2022, 2024
Age at first award
2 years

Projects

2024 Collaborative R&D Lead participant

IMPACT-Farm Alliance: Point-of-care infectious pathogen detection to diagnose disease outbreaks and support vaccine strategy on pig farms

1 Sep 2024 to 31 Aug 2027

Awarded
£1,625,192
Total cost £2,321,703

Infections spread within pig herds can be catastrophic for farmers, causing deaths, decreasing productivity and promoting the rise of antimicrobial resistance. Diagnostics and vaccines are the best tools to combat infectious diseases. However, current porcine testing takes a week or more to complete and often focus on one pathogen at a time, preventing fa...

2022 Collaborative R&D Lead participant

PERP-ID: On farm point-of-care diagnostic for the porcine respiratory disease complex

1 May 2022 to 30 Apr 2024

Awarded
£206,493
Total cost £294,989

Lung infections are responsible for substantial suffering, deaths, and economic loss in the UK and worldwide pig industry. Infections are caused by bacteria, viruses or a combination of the two. Control of lung infections is by the use of good farm practices (e.g., avoiding overcrowding), antibiotics and/or vaccines. However, antimicrobial resistance is a...

Product types

Collaborative R&D